We are now offering the FDA-approved and insurance-covered treatment, Esketamine (Spravato), at The
Neuropsychiatry and TMS Group.
This technology was FDA-approved in 2008 to treat people with depression who have not responded to antidepressants. It was an extremely important development in the field of psychiatry for several reasons. The main reason is that depression is difficult to treat in about half of people who develop it. Tampa Neuropsychiatry St. Petersburg will be offering TMS.
This technology was FDA-approved in 2008 to treat people with depression who have not responded to antidepressants. It was an extremely important development in the field of psychiatry for several reasons. The main reason is that depression is difficult to treat in about half of people who develop it. Tampa Neuropsychiatry St. Petersburg will be offering TMS.
